FDA votes to keep black box warning on Pfizer anti-smoking drug

Oct 16 (Reuters) - Pfizer Inc failed in its attempt to remove a black box warning from its controversial quit-smoking drug, Chantix, after an advisory panel to the U.S. Food and Drug Administration voted against the removal.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.